Archive for the ‘Cell Therapy’ Category

Stem Cell Therapy for Autism Part 1
He is a known case of Autism with history of full term caesarean section delivery and cried immediately after birth with near normal motor milestones. But as he was put in school, there were regular complaints of him being hyperactive. He was then diagnosed to have Autism. He was shifted to special school then. Neurologically, he has near normal tone, reflexes and muscle power. On examination: he has hyperactivity. He has aggressive behaviour with episodes of violence and beating others. He has repetitive speech (echolalia), but it is need based. He has social isolation. He is bowel bladder trained. He is independent in most ADL. Functionally, he needs supervision in most ADL. On FIM he scores 106. After Stem Cell Therapy 1. Angry spells are short lasting than before. Earlier, if he used to be upset for half hour at a stretch, now he calms down in 2 minutes. 2. Did not ask for toothpaste for second time which he used to do daily. 3. He does not insist on bathing 2-3 times a day like before. Now, he takes bath once a day. 4. Visits washroom once in 2-3 hours and then washes his hand normally and leaves the washroom. Earlier, he used to go to washroom every hourly and wash his hand, spill water on his clothes and arms. 5. Eye contact attention span improved. 6. Sitting tolerance improved and attends for 30 mins session. 7. Listening skills and observation skills on demand improved. 8. Screaming behavior reduces when given paper tearing activity. 9. His parents feel his ...

By: neurogenbsi

Here is the original post:
Stem Cell Therapy for Autism Part 1 - Video

Stem Cell Therapy for Autism Part 1 Tamil
He is a known case of Autism with history of full term caesarean section delivery and cried immediately after birth with near normal motor milestones. But as he was put in school, there were regular complaints of him being hyperactive. He was then diagnosed to have Autism. He was shifted to special school then. Neurologically, he has near normal tone, reflexes and muscle power. On examination: he has hyperactivity. He has aggressive behaviour with episodes of violence and beating others. He has repetitive speech (echolalia), but it is need based. He has social isolation. He is bowel bladder trained. He is independent in most ADL. Functionally, he needs supervision in most ADL. On FIM he scores 106. After Stem Cell Therapy 1. Angry spells are short lasting than before. Earlier, if he used to be upset for half hour at a stretch, now he calms down in 2 minutes. 2. Did not ask for toothpaste for second time which he used to do daily. 3. He does not insist on bathing 2-3 times a day like before. Now, he takes bath once a day. 4. Visits washroom once in 2-3 hours and then washes his hand normally and leaves the washroom. Earlier, he used to go to washroom every hourly and wash his hand, spill water on his clothes and arms. 5. Eye contact attention span improved. 6. Sitting tolerance improved and attends for 30 mins session. 7. Listening skills and observation skills on demand improved. 8. Screaming behavior reduces when given paper tearing activity. 9. His parents feel his ...

By: neurogenbsi

Read the original:
Stem Cell Therapy for Autism Part 1 Tamil - Video

WASHINGTON, March 1, 2013 /PRNewswire-USNewswire/ --Family Research Council (FRC) Senior Fellow Dr. David Prentice, a native Kansan, congratulated the Kansas state senate for passing S.B. 199, a bill that would establish the Midwest Stem Cell Therapy Center, a regional hub to advance and deliver adult and cord blood stem cell therapies to patients and serving as a resource for adult and cord blood stem cells for therapies. The Center would also inform professionals and the public about such therapies.

(Logo: http://photos.prnewswire.com/prnh/20080930/FRCLOGO)

Dr. Prentice, a cell biologist who was selected by George W. Bush's Council on Bioethics to write a comprehensive review of adult stem cell research in 2004, testified before the Kansas Senate Committee on Public Health and Welfare in support of S.B. 199 on Feb. 25. Dr. Prentice additionally serves as adjunct professor of molecular genetics at the John Paul II Institute at the Catholic University of America, and formerly served as professor of life sciences at Indiana State University and adjunct professor of medical and molecular genetic at Indiana University School of Medicine.

The bill will now go to the Kansas House of Representatives for consideration.

In his testimony Dr. Prentice said:

"There are significant opportunities right now for Kansas to benefit from the establishment of a center of excellence specializing in the application of adult stem cell therapies for certain diseases, as well as educating physicians as well as the public about the advantages and availability of stem cell treatments.

"Kansas is moving forward as a potential leader in the area of adult and cord blood stem cell therapies. Estimates are that KU Med has done over 1,000 adult stem cell transplants, from bone marrow as well as a growing number from umbilical cord blood. These include stem cell transplants for various cancers and leukemias, but also initiating clinical trials to treat heart damage. Much more is possible.

"Kansas is well-positioned to become a leader in this area, and a global resource. The potential benefits for patients are incalculable. I urge you to support S.B. 199."

To read Dr. Prentice's testimony, click here: http://www.frc.org/testimony/testimony-of-dr-david-prentice-before-the-committee-on-public-health-and-welfare-kansas-senate

SOURCE Family Research Council

Read this article:
FRC's Dr. David Prentice Congratulates Kansas Senate for Passing Ethical Stem Cell Therapy Bill

Cell Therapy Center Emcell
The World #39;s Largest Clinical Experience in Fetal Stem Cell Transplantation Stem Cell Treatment for Various Diseases And Conditions. Anti-Aging Treatment

By: emcellsite

Read the rest here:
Cell Therapy Center Emcell - Video

Stem Cell Therapy Bio1103 Group 29 AM
Peyton Manning and Stem Cell Research

By: megmitchell93

Read more:
Stem Cell Therapy Bio1103 Group 29 AM - Video

Group 52AM- Stem Cell Therapy
Group 52 (BIOL1103/11:00AM) clearly illustrates the topic of Stem Cell Therapy through a class project based on a member of their own group who is considering Stem Cell Therapy.

By: Savannah Kelley

The rest is here:
Group 52AM- Stem Cell Therapy - Video

Age-Related Macular Degeneration and Retinal Stem Cell Therapy
The problems of AMD and its potential treatment with Retinal Stem Cell Therapy BIO 1103 at UGA

By: grayson3447

Read more from the original source:
Age-Related Macular Degeneration and Retinal Stem Cell Therapy - Video

Group 62AM Alzheimer #39;s Stem Cell Therapy
Group 62AM #39;s video for Biology 1103 at UGA

By: Brooke Dillard

See more here:
Group 62AM Alzheimer's Stem Cell Therapy - Video

Now, thanks to participating veterinarians like Dr. Karen Derfuss, DVM, from Branchburg Animal Hospital, who will be conducting a new double stem cell therapy procedure on Tuesday, Feb. 26, and the procedure itself, developed by MediVet America, a new kind of treatment is available for dogs, Auggie and Chloe, and other beloved pets in the Branchburg area.

This new procedure marks a major milestone in regenerative veterinary medicine, said MediVet-America spokesman, Dr. Mike Hutchinson, D.V.M., a leading practitioner in stem cell therapy who has performed more than 400 adipose-derived stem cell treatments on dogs and cats. MediVets superior results made me a believer, and Im excited to share this news with my colleagues.

The procedure uses adult animal stem cell technology and the bodys own regenerative healing power. No embryonic stem cells are used. MediVets kit and equipment enable veterinarians to remove a sample of fat from the pet, separate stem cells from the fat, then activate and inject the cells into the affected area. The entire procedure is all done in-clinic and on the same day.

Within about one month, most animals can be removed from pain and anti-inflammatory drugs. Results show animals that had been unable to climb stairs or jump, now are walking, running and playing.

MediVet is a global leader in veterinary science, with over 1,000 clinics practicing this incredible technology in the US, Mexico, Canada and 28 other countries

About the two dogs:

Auggie is a nine year old loving beagle and a Fathers Day Gift for dad. He is suffering from hip dysplasia, which is an abnormal formation of the hip socket that, in its more severe form, can eventually cause crippling lameness and painful arthritis of the joints. Derfuss is the only doctor in the area who has been certified by MediVet America to perform this double procedure. The stem cell procedure is an affordable and non-invasive alternative to FHO (femoral head osteopathy) surgery, which was originally planned for Auggie.

Chloe is a beautiful 11 year old golden retriever who suffers from bilateral arthritic hips and long term inflammation issues. It was decided to use this new technology to treat Chloes ailments as an alternative to expensive and invasive hip replacement surgery.

View post:
First ever double stem cell therapy procedure to be performed by Branchburg veterinarian

Parkinson #39;s Stem Cell Therapy - Group 28 pm
BIOL 1103 Group 28 pm Stem Cell Application Assignment Sources: Euro Stem Cell research: http://www.eurostemcell.org Michael J. Fox Foundation: http://www.michaeljfox.org

By: thehaysdays

Read the rest here:
Parkinson's Stem Cell Therapy - Group 28 pm - Video

Beckers Muscular Dystrophy After Stem Cell Therapy in Mumbai India
He is a 12 year old and a known case of BMD with history of gradual onset of progressive lower extremities muscle weakness since age of 7 years with complaints of difficulty in climbing stairs, getting up from floor. Weakness even progressed to upper extremities with difficulty in overhead activities and frequent falls. No family history. On examination, he has grade 3 #713; muscle power in proximal muscles of both upper extremities and lower extremities and 4 in distal muscles of both upper extremities and lower extremities. He has bilateral pseudohypertrophy of calf muscles and walks on toes. Neurologically, he is hypotonic and hyporeflexic. Functionally, he is independent in most of the ADL, needs assistance in lower body dressing. On FIM he score 109. After Stem Cell Treatment 1. Reports overall feeling of freshness and energetic. 2. Can manage to walk on heels. Earlier he would walk on toes. 3. Posture has improved. Earlier he would walk with lordosis. 4. Earlier he would need maximum support for stair climbing from both railing and one hand on knee, now only uses railing to climb stairs. 5. Stamina has improved and he has increased level of confidence. 6. Sit to stand and stand to sit transfers requires less efforts. 7. Can perform overhead activities with ease and maintains for a longer time. 8. Is more active than before. 9. Speech is clear and loud followed by deep inhalation and slow rate with prolongation technique. 10. Secondary behaviors also reduced like reduced ...

By: neurogenbsi

Continued here:
Beckers Muscular Dystrophy After Stem Cell Therapy in Mumbai India - Video

Inclusive Body Myopathy Improvement After Stem Cell Therapy in Mumbai India
He is a case of Inclusive Body Myopathy, since last 16 years with the history of slowness in running speed and slipping of "chappals" while walking and following foot drop. Weakness is progressive in nature and now involved muscles of all 4 limbs and trunk. Since last 3 years he is bedridden. Muscle biopsy is showing Inclusive Body Myopathy and EMG-NCV reports are showing generalized primary muscle disease. His elder sister also suffering from the same problem. Neurologically, he is hypotonic and hyporeflexic. On examination: he has grade 1+ muscle power in all 4 limbs proximally and grade 0 foot muscles and grade 3 distal muscles of upper limbs. Proximal muscle weakness is more than distal. Functionally, he is dependent in all ADL and mobility. On FIM he scores 48. After Stem Cell Treatment 1. Stamina has increased. 2. He can do suspension exercises for more range of motion and with more repetition without fatigue. 3. Now he can initiate rolling. He takes less support for rolling and turning. Earlier he used to change his position 4-5 times because of discomfort, but now he needs to change his position only once at night. 4. He can initiate supine to sit. 5. He is able to perform side lying to sitting by himself upto 70%. 6. Attempted drinking water in modified manner with right hand, which he couldn #39;t do before. Stem Cell Therapy done at Dr Alok Shrama NeuroGen Brain and Spine Institute Surana Sethia Hospital Sion-Trombay Rd, Suman Ngr Opp Corporate Park, Chembur ...

By: neurogenbsi

See the original post:
Inclusive Body Myopathy Improvement After Stem Cell Therapy in Mumbai India - Video

Hypoxic Ischaemic Brain Injury Improvement After Stem Cell Therapy in Mumbai India
He is a case of Hypoxic Brain Injury since 4 years. Because of high grade fever of "chikungunya", he got cardiac arrest and went into coma for 1 year. During comatose stage, he had sacral and Greater Trochanter sores which are all recovered and he has developed myositis ossification at bilateral hip and right elbow. Hip myositis ossification was removed surgically. After comatose stage, he has recovered in speech and voluntary control. He has developed rigidity in trunk and lower extremities. In 2011,he had history of fall while walking and had right femur shaft fracture which was treated surgically with plate and screws in place. Neurologically, he is hypertonic and hyperreflexic. On examination, he has restricted range of motion of bilateral hip, knee and ankle and right elbow. Voluntary control of lower extremities is poor while voluntary control of upper extremities is fair. He has rigidity in bilateral lower extremities and spasticity of grade 2 in upper extremities muscles. Patient is dependent for all ADL. On FIM he scores 30. After Stem Cell Treatment 1. He feels ease in getting up from supine to sit. 2. He can sit straight for some time (5-10 minutes) ,earlier easily stoop in 5-10 seconds. 3. His sitting balance is improved than before, earlier had fear to tilt sideways. 4. His spasticity in lower limb has reduced. 5. His speech has become clear and with proper pauses. 6. He can do roll over on bed with ease and less assistance from caretaker than before. Stem ...

By: neurogenbsi

Read more from the original source:
Hypoxic Ischaemic Brain Injury Improvement After Stem Cell Therapy in Mumbai India - Video

Spinal Cord Injury Improvement After Stem Cell Therapy in Mumbai India
She is a known case of Spinal Cord Injury since age of 1 year. After trauma she lost sensations of motor power below D6 level and on bowel bladder. MRI report showed 1) tiny focal traumatic contusion in cervical and upper dorsal spinal cord. 2) Grade 1 listhesis at C6-7 level. 3) Thin pre vertebral and anterior epidural hematoma. Initially she got good physiotherapy rehabilitation. She recovered in terms of bowel and bladder sensation, 50%. She has developed scoliosis (convexity towards right side) due to weakness of paravertebral muscles. Neurologically, she is hypertonic and hyperreflexic. She has ankle clonus. On examination: she has sensory loss below T6 level. She has grade 0 muscle power in bilateral lower extremities and near normal upper extremities strength. She is following time voiding for urination and she passes stool once in every 2-3 days. She has no pressure sores. On ASIA scale she scores "A". Functionally, she needs assistance in most ADL and wheelchair bound for mobility. On WeeFIM she scores 53. After Stem Cell Therapy 1. Exercises tolerance has increased. 2. Sitting posture is better. 3. She sits more erect now. Earlier, she used to stoop to one side. 4. Parents report that she responds to pain (being pinched on the side) now. Earlier would not be able to appreciate. Stem Cell Therapy done at Dr Alok Sharma NeuroGen Brain and Spine Institute Surana Sethia Hospital Sion-Trombay Rd, Suman Ngr Opp Corporate Park, Chembur, Mumbai -- 71. Tel : 022 ...

By: neurogenbsi

Follow this link:
Spinal Cord Injury Improvement After Stem Cell Therapy in Mumbai India - Video

Autism Improvement After Stem Cell Therapy in Mumbai India
He is a known case of Autism with history of full term normal delivery, cried immediately after birth. He had near normal motor milestones with delayed speech. On examination, he has poor eye contact, poor concentration, poor attention span, poor language command. He is stubborn and aggressive (decreased with rehabilitation). He goes to normal school and had good memory but poor in social communication. On ISAA scale he scores 90. On WeeFIM, he scores 77. After Stem Cell Therapy Psychology assessment: 1) His attention and concentration has improved by 25%. Previously his remedial educator would take him in a group session as he would do an activity only under a competitive spirit whereas now he can even study alone. 2) Eye contact has improved. 3) His quantity and quality of vocabulary has improved about 25%. 4) Now, he is able to form sentences of 4-5 words whereas previously his speech was bisyllables. 5) Now he is able to formulate meaningful sentences and have a meaningful conversation. 6) Now he is learning new mathematical concepts and mother and teachers feel that study wise there are real good improvements. 7) Memory has improved ie now he is able to reproduce and recollect whatever has been taught to him in the school. 8) Speech therapist mentioned that he now does not require speech therapy whereas he now requires OT and remedial education. 9) Social interaction is better ie now he can initiate and engage himself and other people into an activity or conversation ...

By: neurogenbsi

Go here to read the rest:
Autism Improvement After Stem Cell Therapy in Mumbai India - Video

Stem Cell Therapy at Integra Medical Center
New Project 82

By: Omar Gonzalez

Continued here:
Stem Cell Therapy at Integra Medical Center - Video

Broadcast journalist says the results are dramatic By Cheche V. Moral Philippine Daily Inquirer

DAVILA and her firstborn David at age 10

You can point a mother to the ends of the earth and it wont weaken her resolve to find that cure for her ailing child.

Broadcast journalist Karen Davilas firstborn, David, was 3 years old when he was diagnosed with Pervasive Developmental Disorder, Not Otherwise Specified (PDD/NOS) in the Autism Spectrum, a severe form of autism. The development pediatrician said there was no cure for Davids condition.

David didnt have the classic signs of autism, but clearly he wasnt developing like other children his age, says Davila. At the age of 3, he wasnt speaking spontaneously, although he could read. He had tantrums, couldnt express his needs, whether he was hungry or sad, and didnt reach out to other children his age.

Like most kids in the autism spectrum, the boy had attention difficulties. He was spaced out most of the time, and was rigid. It was so heartbreaking to see my eldest this way, she adds.

Davila refused to accept that there was no answer to her sons condition. I researched endlessly and devoted myself to making sure my son got the best possible treatment, she says. She quickly put her son on a casein- and gluten-free diet and biomedical treatment, under the care of Defeat Autism Now (DAN)-licensed doctors.

Davila explains that kids like David lack an enzyme in the body to digest casein, a protein found in cows milk, and gluten, a protein found in wheat, oats, barley and rye. When they take [casein and gluten], it feels like opium in the body, so kids feel high, theyre so hyper, get wild and are spaced out.

David, now 11, has also undergone anti-fungal treatments, and has been taking supplements and B12 injections to help his attention issues. He has also benefited from the help of occupational and speech therapists. Now in Grade 5, David is in his grade level in Multiple Intelligence School, in a smaller class ratio, according to his mother.

Early last year, Davila was offered an opportunity to try the fresh cell therapy being offered by a clinic in Germany called Villa Medica. The stem cells are harvested from lamb fetus and injected into the patient. By then, the journalist-mom had read up on the supposed benefits of stem cell on children with special needs.

Continued here:
Karen Davila resorts to stem-cell therapy for son’s autism

Published on 10 January 2013 Hits: 1,020 Written by Jovee Marie N. Dela Cruz

A HEALTH expert on Wednesday warned that stem cell therapy can also kill.

Dr. Leo Olarte, spokesman of the Philippine Society for Stem Cell Medicine, said that if the stem cell that a patient received is from a donor, it could lead to fatal complications.

He said that a stem cell transplant can pose risks of complications, some potentially fatal, depending on many factors including the type of blood disorder, the type of transplant and the age and health of the person.

Although some people experience few problems with a transplant, others may develop complications that may require treatment or hospitalization. Some complications could even be life-threatening, warned Olarte, also the vice chairman of the Philippine Medical Association.

He said that such complications could be in the form of graft-versus-host disease (allogeneic transplant only), stem cell (graft) failure, organ injury, infections, cataracts, infertility, new cancers and even death.

Olarte said that anyone undergoing a transplant using stem cells from a donor (allogeneic stem cell transplant) may be at risk of graft-versus-host disease.

This condition occurs when a donors transplanted stem cells attack your body. Graft-versus-host disease can be mild or severe. It can occur soon after your transplant or months to years later, he added.

The doctor said that incompatibility can also lead to diseases of the skin (rash, often like sunburn), gut (mouth sores, abdominal pain, diarrhea, nausea or vomiting), liver (jaundice or yellowing of the skin), lungs (blocked airways) or eyes (irritation and light sensitivity).

It can lead to chronic disability due to organ injury or infections and can be life-threatening. Your doctor must monitor closely for signs and symptoms of graft-versus-host disease, Olarte said.

Continued here:
Stem cell therapy can kill – health expert

Stemlogix Stem Cell therapy at Central Animal Hospital St Petersburg Florida
Central Animal Hospital of St Petersburg, FL now offers in house Stemlogix Stem Cell Therapy for osteoarthritis for dogs! More info: http://www.centralanimal.net or http://www.tbk9rehab.com

By: StemLogixLLC

Here is the original post:
Stemlogix Stem Cell therapy at Central Animal Hospital St Petersburg Florida - Video

Stem Cell Therapy Testimonial - Arthritis Treatment (full version)
Stem Cell Therapy Testimonial - Arthritis Treatment (full version) 1-888-545-4333

By: Bofitmiami

Continued here:
Stem Cell Therapy Testimonial - Arthritis Treatment (full version) - Video

Stem Cell Therapy Testimonial - Arthritis Treatment (Short Version)
Stem Cell Therapy Testimonial - Arthritis Treatment (Short Version) 1-888-545-4333

By: Bofitmiami

Read this article:
Stem Cell Therapy Testimonial - Arthritis Treatment (Short Version) - Video

Pet Surgery | Las Vegas | Veterinary Stem Cell Therapy | TPLO
veterinary-stemcell.com 702-250-1888 What is stem cell therapy? Stem cells are the body #39;s repair cells. They have the ability to divide and differentiate into many different types of cells based on where they are needed throughout the body. Stem cells can divide and turn into tissues such as skin, fat, muscle, bone, cartilage, and nerve to name a few. They even possess the ability to replicate into organs such as the heart, liver, intestines, pancreas, etc. Call Dr. Mauer or visit his site today.. Find out if stem cell therapy is right for your pet.

By: Roger Mauer

Originally posted here:
Pet Surgery | Las Vegas | Veterinary Stem Cell Therapy | TPLO - Video

Stem Cell Therapy For Your Pet | Las Vegas, Nevada | Dr. Roger A. Mauer DVM
veterinary-stemcell.com Dr. Mauer is very excited to now be offering Stem Cell Therapy. This innovative and affordable treatment has been making news all over the country. This treatment is completely natural and there are no side effects other than occasional minor swelling at injected joint sites. Most animal owners see results in just days after treatment and their pets benefiting with less or no pain. Stem cells are the body #39;s repair cells. They have the ability to divide and differentiate into many different types of cells based on where they are needed throughout the body. Stem cells can divide and turn into tissues such as skin, fat, muscle, bone, cartilage, and nerve to name a few. They even possess the ability to replicate into organs such as the heart, liver, intestines, pancreas, etc.

By: Roger Mauer

The rest is here:
Stem Cell Therapy For Your Pet | Las Vegas, Nevada | Dr. Roger A. Mauer DVM - Video

Dundas West Animal Hospital Stem Cell Therapy

By: MakeMeVideo

Visit link:
Dundas West Animal Hospital Stem Cell Therapy - Video

SAN DIEGO, Jan. 31, 2013 /PRNewswire/ -- ViaCyte, Inc., a leading regenerative medicine company focused on developing new approaches to treat major diseases through the application of a stem cell-derived cell therapy, announced today that the Company was granted 20 patents worldwide in 2012, eight U.S. and twelve foreign. These patents bolster the Company's already strong proprietary position for its ground-breaking diabetes product, VC-01, as well as other applications of its broad technology platform.

(Logo: http://photos.prnewswire.com/prnh/20121026/LA00871LOGO-a)

VC-01 is a very promising, development-stage product that consists of pancreatic precursor cells (called PEC-01) derived from a proprietary human embryonic stem cell line and encapsulated in a proprietary, immune isolating medical device (the ENCAPTRA device). When implanted under the skin in suitable animal models, the cells further differentiate into insulin producing and other endocrine cells that regulate blood glucose in a manner similar or identical to a normal pancreas. If VC-01 performs in humans as it has in animal studies, it could effectively cure type 1 diabetics and be an important new therapy for insulin dependent type 2 diabetics.

ViaCyte's significant intellectual property portfolio now includes over 300 issued patents and pending applications related to the growth, directed differentiation and use of human pluripotent stem cells such as human embryonic stem cells and induced pluripotent stem cells. This portfolio includes 51 issued U.S. and foreign patents specifically directed to the Company's VC-01 product. In addition to the protection afforded by patents, the Company also relies on significant proprietary know-how to develop its product offerings.

Dr. Paul Laikind, ViaCyte's president and chief executive officer said, "Our comprehensive and growing intellectual property portfolio helps to establish us as a leading company in the cell therapy and regenerative medicine field. Although the Company's resources are currently fully committed to the rapid development of VC-01 as a potentially transformative treatment for patients with insulin-dependent diabetes, our platform technology has many other important applications."

In July and August of 2012, the Board of Patent Appeals and Interferences of the U.S. Patent and Trademark Office (the "Board") also issued two decisions favoring ViaCyte on motions filed in the patent interference proceedings between ViaCyte and Geron Corporation (Menlo Park, California). The interferences involved ViaCyte's U.S. Patent No. 7,510,876 ("876 Patent"), which is directed to human definitive endoderm cell cultures in vitro. The Board upheld the claims of ViaCyte's '876 Patent in its entirety over Geron's applications. In September 2012, Geron appealed this decision in the United States District Court for the Northern District of California.

About ViaCyteViaCyte, a private company that has emerged as a leader in the field of regenerative medicine, is currently focused on developing a novel cell therapy for the treatment of diabetes. The Company's lead product is based on the production of pancreatic progenitors derived from human pluripotent stem cells. These cells are implanted in a durable and retrievable encapsulation device. Once implanted and matured, these cells secrete insulin and other regulatory factors in response to blood glucose levels. ViaCyte's goal for this potentially transformative diabetes product is long term insulin independence without immune suppression, and without risk of hypoglycemia and other diabetes-related complications.

ViaCyte is headquartered in San Diego, California with additional operations in Athens, Georgia. The Company is funded in part by the California Institute for Regenerative Medicine (CIRM) and JDRF.

Read the original here:
ViaCyte's Role as a Leading Cell Therapy Company Bolstered with the Issuance of 20 Patents in 2012